Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Quigley Corporation (NasdaqNM:QGLY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
Kells Building, 621 Shady Retreat Road
Doylestown, PA 18901
Phone: (215) 345-0919
Fax: (215) 345-5920
Email: quigley@www.quigley.com
Employees (last reported count): 22
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 51%
·Over the last 6 months:
 · 2 insider buys; 40.0K shares (0.7% of insider shares)
·Institutional: 3% (5% of float)
(12 institutions)
·Net Inst. Buying: 15.0K shares (+5.32%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
The Quigley Corporation's primary business is the manufacture and distribution of cold remedy products to the consumer through the over-the-counter marketplace. Its key product, Cold-Eeze, is a zinc gluconate glycine lozenge, which, in two double-blind clinical studies, reduced the duration and severity of the common cold symptoms. Since its inception, the Company has continued to conduct research and development into various types of health-related food supplements and homeopathic cold remedies. In January 2000, Darius International, Inc. a wholly owned subsidiary of the Company, was formed as a means of introducing new products to the marketplace. Additionally, effective July 1, 2000, the Company acquired a 60% ownership position in Caribbean Pacific Natural Products.
More from Market Guide: Expanded Business Description

Financial Summary
QGLY is engaged in the business of marketing of health products such as cold remedy Cold-Eeze(R). QGLY also has a nutrition and weight management program called Bodymate(TM). For the six months ended 6/30/01, total revenues rose 51% to $9.4 million. Net loss fell 81% to $1.1 million. Revenues reflect a $1.3 million settlement fee in the lawsuit against Gel Tech and Gum Tech International and an increase in Cold-Eeze sales. Lower loss reflects decreased advertising expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Guy Quigley, 59
Chairman, Pres and CEO
$1.1M$206K
Charles Phillips, 53
Exec. VP, COO
584K--  
George Longo, 54
VP, CFO
331K--  
Eric Kaytes, 46
VP, CIO, Sec., Treasurer
258K62K
Joseph Casey
VP of Sales and Marketing
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:QGLYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 28-Dec-2000
$0.656
Recent Price$1.00 
52-Week High
on 28-Sep-2000
$1.969
Beta0.76 
Daily Volume (3-month avg)13.4K
Daily Volume (10-day avg)18.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-30.5%
52-Week Change
relative to S&P500
-6.7%
Share-Related Items
Market Capitalization$10.7M
Shares Outstanding10.7M
Float5.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.86 
Earnings (ttm)-$0.07 
Earnings (mrq)-$0.06 
Sales (ttm)$2.14 
Cash (mrq)$0.81 
Valuation Ratios
Price/Book (mrq)0.54 
Price/EarningsN/A 
Price/Sales (ttm)0.47 
Income Statements
Sales (ttm)$22.6M
EBITDA (ttm)-$1.45M
Income available to common (ttm)-$705.0K
Profitability
Profit Margin (ttm)-3.9%
Operating Margin (ttm)-6.4%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-3.57%
Return on Equity (ttm)-3.42%
Financial Strength
Current Ratio (mrq)6.94 
Debt/Equity (mrq)0 
Total Cash (mrq)$8.70M
Short Interest
As of 8-Aug-2001
Shares Short47.0K
Percent of Float0.9%
Shares Short
(Prior Month)
47.0K
Short Ratio11.75 
Daily Volume4,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.